Goldman Sachs
IBIO icon

Goldman Sachs’s iBio IBIO Stock Holding History

Goldman Sachs’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$380K Buy
+200,212
New +$465K ﹤0.01% 5762
2022
Q3 		– Sell
-587
Closed -$78K – 6396
2022
Q2 		$78K Buy
587
+329
+128% +$49.5K ﹤0.01% 5932
2022
Q1 		$55K Sell
258
-473
-65% -$99K ﹤0.01% 6247
2021
Q4 		$201K Buy
731
+260
+55% +$99.1K ﹤0.01% 5902
2021
Q3 		$250K Buy
471
+293
+165% +$182K ﹤0.01% 5604
2021
Q2 		$134K Buy
178
+14
+9% +$10.2K ﹤0.01% 5872
2021
Q1 		$126K Buy
164
+110
+204% +$95.8K ﹤0.01% 5776
2020
Q4 		$29K Buy
54
+29
+116% +$23.6K ﹤0.01% 5421
2020
Q3 		$26K Sell
25
-115
-82% -$167K ﹤0.01% 5238
2020
Q2 		$156K Sell
140
-54
-28% -$35.3K ﹤0.01% 4880
2020
Q1 		$103K Buy
+194
New +$74.7K ﹤0.01% 4936
2016
Q2 		– Sell
-18
Closed -$50K – 7117
2016
Q1 		$50K Buy
+18
New +$51.6K ﹤0.01% 6432

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return